These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22325213)
1. [Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces anti-tumor immune response]. Zhang JM; Wu XH; Zhang X; Zhang Y; Luo CL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):564-9. PubMed ID: 22325213 [TBL] [Abstract][Full Text] [Related]
2. [Preparation of renal cancer vaccine of IL-12-anchored exosomes and its antitumor effect in vitro]. Zhang Y; Wu XH; Chen G; Luo CL; Zhang JM Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):339-43. PubMed ID: 20723430 [TBL] [Abstract][Full Text] [Related]
3. Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces antitumor immune response in vitro. Zhang J; Zhang Y; Luo C; Xia Y; Chen H; Wu X Tumori; 2010; 96(3):452-9. PubMed ID: 20845808 [TBL] [Abstract][Full Text] [Related]
4. [Exosomes derived form bladder transitional cell carcinoma cells induce CTL cytotoxicity in vitro]. Zhang JM; Wu XH; Zhang Y; Xia YG; Luo CL Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):738-41. PubMed ID: 20021824 [TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Zhang Y; Luo CL; He BC; Zhang JM; Cheng G; Wu XH Int J Oncol; 2010 Jan; 36(1):133-40. PubMed ID: 19956842 [TBL] [Abstract][Full Text] [Related]
6. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice. Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579 [TBL] [Abstract][Full Text] [Related]
7. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination. Nagarajan S; Selvaraj P Vaccine; 2006 Mar; 24(13):2264-74. PubMed ID: 16376465 [TBL] [Abstract][Full Text] [Related]
8. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Dai S; Wan T; Wang B; Zhou X; Xiu F; Chen T; Wu Y; Cao X Clin Cancer Res; 2005 Oct; 11(20):7554-63. PubMed ID: 16243831 [TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12. Ji J; Li J; Holmes LM; Burgin KE; Yu X; Wagner TE; Wei Y J Gene Med; 2004 Jul; 6(7):777-85. PubMed ID: 15241785 [TBL] [Abstract][Full Text] [Related]
10. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response. Nagarajan S; Selvaraj P Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166 [TBL] [Abstract][Full Text] [Related]
11. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
13. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro. Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038 [TBL] [Abstract][Full Text] [Related]
15. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
16. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells]. Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108 [TBL] [Abstract][Full Text] [Related]
17. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913 [TBL] [Abstract][Full Text] [Related]